Jack W. Lasersohn has over twenty-five years of experience in health care venture capital investments. Prior to joining The Vertical Groupís predecessor, F. Eberstadt in 1981, Mr. Lasersohn was a corporate attorney with Cravath, Swaine & Moore. Mr. Lasersohn currently serves on the Boards of Directors of Alsius Corporation, Bacchus Vascular, Inc., Kyphon Inc., Masimo Corporation, Metabolix, Inc., Oncomed, Photothera, Proteolix , Timi3 Systems, Inc. and TetraLogic Pharmaceuticals. He previously served on the boards of CardioThoracic Systems, Inc., Cardiovascular Imaging Systems, Inc., and E.P. Technologies. He received a B.S. degree in Physics from Tufts University, an M.A. from The Fletcher School of Law and Diplomacy, and a J.D. from Yale Law School.